Delivery Order SPE2DB20D1100-SPE2DB25FA0W4

Award Date 1/15/25
Potential Completion Date 1/16/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,228.50 fixed-price delivery order is for the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a period of performance through March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,735.57, is for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,874.78, is a delivery order for the pharmaceutical product WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC enables...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,638.00, is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with a completion date of March 18, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,686.13, is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. It is a firm fixed-price delivery order contract with a completion date of March 7, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,435.84, is for the delivery of the medication WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,638.00, is a delivery order for the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price contract. Amerisourcebergen is the prime contractor, and there is no indication of any set-aside designation for this award. The...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,221.87, is for the supply of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. The contract has a completion date of February 27, 2025 and is a firm fixed-price contract. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,886.32, is for the delivery of the drug WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. This is a Firm Fixed Price delivery order contract with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $3,272.64, is for the delivery of the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. The contract has a completion date of February 20, 2025 and is a firm fixed-price delivery order. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA0W4
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,276.00, is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. It is a firm fixed-price delivery order contract with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/17/25, 9:09 AM